InsiderTrades

Form 4 for HCAT Health Catalyst, Inc.

Accepted 2021-09-08 00:00:00 ET · period of report 2021-09-03 · accession 0001562180-21-005873 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2021-09-08 2021-09-03+ HCAT Hinton Bryan Richard CTO S - Sale+OE $54.87 -2,282 18.8K -11% -$125.2K
D 2021-09-08 2021-09-03 HCAT Hinton Bryan Richard CTO M - OptEx $10.80 +106 21.0K +0.5% +$1,145
D 2021-09-08 2021-09-03 HCAT Hinton Bryan Richard CTO M - OptEx $0.00 -106 846 -11% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-09-03 S D 106 $54.23 20,926 D — —
2 Common Common Stock 2021-09-03 M A 106 $10.80 21,032 D — —
3 Common Common Stock 2021-09-07 S D 2,176 $54.90 18,750 D — — (F3) Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $54.78 to $55.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth within this Footnote.
4 Derivative Stock Option (Right to Buy) 2021-09-03 M D 106 $0.00 846 D $10.80 · — to 2028-05-03 106 Common Stock (F4) 25% of the 5,082 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on May 3, 2022.